Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides
Open accessAbstract
Remnants of triglyceride-rich lipoproteins (TRL) have been implicated in the early development of atherosclerosis. We tested this hypothesis by quantifying the plasma concentration of remnant-like particle cholesterol (RLP-C) in a cohort of healthy 50-year-old men in whom the common carotid artery intima-media thickness (CCA-IMT) was assessed by B-mode ultrasound as a surrogate marker for atherosclerosis. The subjects were given a fat-rich meal to study the generation of RLP-C during postprandial lipemia. Fasting plasma RLP-C and other major fasting plasma lipids and lipoproteins were determined twice, and the mean RLP-C concentration was strongly correlated with CCA-IMT (r = 0.32, P = 0.002). In addition, low density lipoprotein (LDL) cholesterol (r = 0.25, P = 0.01) and plasma triglycerides (r = 0.20, P = 0.05) were significantly related to CCA-IMT. Multivariate analyses showed a triglyceride-independent contribution of RLP-C to CCA-IMT. After fat intake, the median plasma RLP-C concentration was doubled after 3 h. The increase was strongly related to the postprandial generation of TRL apolipoprotein (apo)B-48, and large (S(f) 60;-400) TRL apoB-100. The association with CCA-IMT was somewhat stronger for the 3-h RLP-C level than for the fasting RLP-C concentration [r = 0.27, P < 0.01 (3 h) compared with r = 0.22, P < 0.05 (0 h)]. We conclude that the plasma concentration of RLP-C is related to CCA-IMT, independent of plasma triglycerides and LDL cholesterol, in a healthy middle-aged male population. - Karpe, F., S. Boquist, R. Tang, G. M. Bond, U. de Faire, and A. Hamsten. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J. Lipid Res. 2001. 42: 17;-21.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Elevated levels of cholesterol-enriched remnant lipoproteins contribute to the development of premature coronary and peripheral atherosclerosis.
“As a result, elevated levels of cholesterol-enriched remnant lipoproteins contribute to the development of premature coronary [22,23,24] and peripheral [25,26] atherosclerosis.”
From Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia (2024) · cites this paper as [25]
The Discussion (page not provided) reports an association between remnant-like particle cholesterol and carotid intima-media thickness, a surrogate marker of early atherosclerosis. This supports a link to early carotid artery changes, but the study does not establish that elevated remnants cause peripheral atherosclerosis; its coronary discussion describes a previous study rather than a finding of this one. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Carlson, K. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.32 · Cited by 420 · see citing works
Nakajima, K., SAITO, T., Tamura, A., Suzuki, M., Nakano, T., Adachi, M., Tanaka, A., Tada, N., Nakamura, H., Campos, E. M., et al. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90062-9 · Cited by 417 · see citing works
Phillips, A. N., & Smith, G. D. (1991) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(91)90155-3 · Cited by 275 · see citing works
Boquist, S., Ruotolo, G., Tang, R., Björkegren, J., Bond, M. G., Fairé, U. D., Karpe, F., & Hamsten, A. (1999) · Circulation · doi:10.1161/01.cir.100.7.723 · Cited by 258 · see citing works
Self-citationCampos, E. M., Nakajima, K., Tanaka, A., & Havel, R. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41527-5 · Cited by 185 · see citing works
Karpe, F., & Hamsten, A. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39974-0 · Cited by 182 · see citing works
Self-citationKarpe, F., Fairé, U. D., Mercuri, M. F., BOND, M., Hellénius, M.-L., & Hamsten, A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00184-1 · Cited by 110 · see citing works
Self-citationKarpe, F., Hellénius, M.-L., & Hamsten, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90076-8 · Cited by 97 · see citing works
Self-citationTriglycerides are more important in atherosclerosis than epidemiology has suggested
Durrington, P. N. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00219-6 · Cited by 72 · see citing works
Björkegren, J., Boquist, S., Samnegård, A., Lundman, P., Tornvall, P., Ericsson, C.-G., & Hamsten, A. (2000) · Circulation · doi:10.1161/01.cir.101.3.227 · Cited by 70 · see citing works
Self-citationAlterations of VLDL composition during alimentary lipemia
Björkegren, J., Hamsten, A., Milne, R. W., & Karpe, F. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37443-5 · Cited by 66 · see citing works
Self-citationMarcoux, C., Tremblay, M., Nakajima, K., Davignon, J., & Cohn, J. S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32142-8 · Cited by 61 · see citing works
Marcoux, C., Tremblay, M., Fredenrich, A., Jacques, H., Krimbou, L., Nakajima, K., Davignon, J., & Cohn, J. S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00042-2 · Cited by 57 · see citing works
Mercuri, M. F., Tang, R., Phillips, R. M., & Bond, M. G. (1996) · PubMed · Cited by 23 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Varbo, A., Benn, M., Tybjærg-Hansen, A., Jørgensen, A. B., Frikke-Schmidt, R., & Nordestgaard, B. G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1026 · Cited by 1,115 · see citing works
Lipid and lipoprotein dysregulation in insulin resistant states
Avramoglu, R. K., Basciano, H., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.026 · Cited by 318 · see citing works
Haidari, M., Leung, N. M., Mahbub, F., Uffelman, K. D., Avramoglu, R. K., Lewis, G. F., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200544200 · Cited by 269 · see citing works
Varbo, A., Benn, M., & Nordestgaard, B. G. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.008 · Cited by 251 · see citing works
Nakajima, K., Nakano, T., & Tanaka, A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.013 · Cited by 209 · see citing works
Twickler, T. B., Dallinga-Thie, G. M., Cohn, J. S., & Chapman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000125278.58527.f3 · Cited by 201 · see citing works
Kaysen, G. A., & Eiserich, J. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000111744.00916.e6 · Cited by 185 · see citing works
Postprandial hypertriglyceridemia as a coronary risk factor
Borén, J., Matikainen, N., Adiels, M., & Taskinen, M.-R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.015 · Cited by 182 · see citing works
Pfeuffer, M., Auinger, A., Bley, U., Kraus-Stojanowic, I., Laue, C., Winkler, P., Rüfer, C. E., Frank, J., Boesch‐Saadatmandi, C., Rimbach, G. H., et al. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.08.010 · Cited by 182 · see citing works
Joshi, P. H., Khokhar, A. A., Massaro, J. M., Lirette, S. T., Griswold, M. E., Martin, S. S., Blaha, M. J., Kulkarni, K. R., Correa, A., D'Agostino, R. B., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002765 · Cited by 177 · see citing works
Postprandial lipoprotein metabolism: VLDL vs chylomicrons
Nakajima, K., Nakano, T., Tokita, Y., Nagamine, T., Inazu, A., Kobayashi, J., Mabuchi, H., Stanhope, K. L., Havel, P. J., Okazaki, M., et al. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.04.018 · Cited by 168 · see citing works
Lichtenstein, A. H. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.07.005 · Cited by 147 · see citing works
Remnant Lipoproteins As Strong Key Particles to Atherogenesis
Fujioka, Y., & Ishikawa, Y. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e598 · Cited by 146 · see citing works
Ezetimibe: cholesterol lowering and beyond
Bays, H. E., Neff, D., Tomassini, J. E., & Tershakovec, A. M. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.4.447 · Cited by 145 · see citing works
Postprandial Hyperlipidemia and Remnant Lipoproteins
Masuda, D., & Yamashita, S. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16003 · Cited by 145 · see citing works
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes
Tan, G. D., Fielding, B. A., Currie, J. M., Humphreys, S. M., D�sage, M., Frayn, K. N., Laville, M., Vidal, H., & Karpe, F. (2004) · Diabetologia · doi:10.1007/s00125-004-1619-9 · Cited by 119 · see citing works
Self-citationPostprandial lipemia as a cardiometabolic risk factor
Pirillo, A., Norata, G. D., & Catapano, A. L. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.909394 · Cited by 108 · see citing works
Qin, B., Qiu, W., Avramoglu, R. K., & Adeli, K. (2007) · Diabetes · doi:10.2337/db06-0518 · Cited by 103 · see citing works
Lewis, G. F., Uffelman, K. D., Naples, M., Szeto, L., Haidari, M., & Adeli, K. (2004) · Endocrinology · doi:10.1210/en.2004-1143 · Cited by 99 · see citing works
Apolipoprotein CIII links dyslipidemia with atherosclerosis
Kawakami, A., & Yoshida, M. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e607 · Cited by 98 · see citing works
Non-HDL Cholesterol as a Measure of Atherosclerotic Risk
Packard, C. J., & Saitō, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.6 · Cited by 95 · see citing works
Are the health benefits of fish oils limited by products of oxidation?
Turner, R., McLean, C. H., & Silvers, K. M. (2006) · Nutrition Research Reviews · doi:10.1079/nrr2006117 · Cited by 94 · see citing works
Multiple CHD risk factors in type 2 diabetes: beyond hyperglycaemia
Reaven, G. M. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1462-8902.2001.00037.x · Cited by 92 · see citing works
Recent insights into factors affecting remnant lipoprotein uptake
Williams, K. J., & Chen, K. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328338cabc · Cited by 91 · see citing works
Are Remnant-Like Particles Independent Predictors of Coronary Heart Disease Incidence?
Imke, C., Rodríguez, B. L., Grove, J., McNamara, J. R., Waslien, C., Katz, A. R., Willcox, B. J., Yano, K., & Curb, J. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000173310.85845.7b · Cited by 89 · see citing works
Koga, H., Sugiyama, S., Kugiyama, K., Fukushima, H., Watanabe, K., Sakamoto, T., Yoshimura, M., Jinnouchi, H., & Ogawa, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi746 · Cited by 87 · see citing works
Koutsari, C., Karpe, F., Humphreys, S. M., Frayn, K. N., & Hardman, A. E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095553 · Cited by 79 · see citing works
Self-citationHomma, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.265 · Cited by 78 · see citing works
Remnant lipoproteins and atherosclerosis
Twickler, T. B., Dallinga‐Thie, G. M., Chapman, M. J., & Cohn, J. S. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0037-x · Cited by 68 · see citing works
Nakajima, K., Nagamine, T., Fujita, M., Ai, M., Tanaka, A., & Schaefer, E. J. (2014) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800263-6.00003-3 · Cited by 67 · see citing works
Lipaemia, Inflammation and Atherosclerosis
van Oostrom, A. J. H. H. M., van Wijk, J. P. H., & Cabezas, M. C. (2004) · Drugs · doi:10.2165/00003495-200464002-00004 · Cited by 67 · see citing works
MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
Solly, E., Dimasi, C., Bursill, C., Psaltis, P., & Tan, J. T. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122199 · Cited by 61 · see citing works
Heritability of carotid intima-media thickness: A twin study
Zhao, J., Cheema, F. A., Bremner, J. D., Goldberg, J. H., Su, S., Snieder, H., Maisano, C., Jones, L. R., Javed, F., Murrah, N. V., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.030 · Cited by 63 · see citing works
Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis
Nakajima, K., & Tanaka, A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.12.039 · Cited by 53 · see citing works
Chen, K., Liu, M., Schaffer, L., Li, M., Boden, G. H., Wu, X., & Williams, K. J. (2010) · Hepatology · doi:10.1002/hep.23916 · Cited by 56 · see citing works
Lewis, G. F., Naples, M., Uffelman, K. D., Leung, N. M., Szeto, L., & Adeli, K. (2004) · Endocrinology · doi:10.1210/en.2003-1559 · Cited by 56 · see citing works
The close relationship between postprandial remnant metabolism and insulin resistance
Funada, J., Sekiya, M., Otani, T., Watanabe, K., Sato, M., & Akutsu, H. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.09.016 · Cited by 56 · see citing works
Toth, P. P., Fazio, S., Wong, N. D., HULL, M. L., & Nichols, G. A. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13921 · Cited by 55 · see citing works
Blackburn, P., Lamarche, B., Couillard, C., Pascot, A., Tremblay, A., Bergeron, J., Lemieux, I., & Després, J. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3303 · Cited by 52 · see citing works
Granér, M., Kahri, J., Varpula, M., Salonen, R. M., Nyyssönen, K., Jauhiainen, M., Nieminen, M. S., Syvänne, M., & Taskinen, M.-R. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.003 · Cited by 53 · see citing works
Remnant Lipoproteins and Atherogenesis
Kawakami, A., & Yoshida, M. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.73 · Cited by 51 · see citing works
Postprandial lipemia—effect of lipid-lowering drugs
Karpe, F. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)00004-6 · Cited by 50 · see citing works
Self-citationPostprandial Lipemia in Hypertension
Kolovou, G. D., Daskalova, D. C., Iraklianou, S. A., Adamopoulou, E. N., Pilatis, N. D., Hatzigeorgiou, G., & Cokkinos, D. V. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719279 · Cited by 48 · see citing works
Gill, J., Al-Mamari, A., Ferrell, W., Cleland, S., Sattar, N., Packard, C., Petrie, J., & Caslake, M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.009 · Cited by 51 · see citing works
Levy, E. H., Spahis, S., Ziv, E., Marette, A., Elchebly, M., Lambert, M. A., & DELVIN, E. E. (2006) · Diabetologia · doi:10.1007/s00125-006-0315-3 · Cited by 49 · see citing works
Ohira, M., Endo, K., Oyama, T., Yamaguchi, T., Ban, N., Kawana, H., Nagayama, D., Nagumo, A., Saiki, A., Murano, T., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2010.06.001 · Cited by 47 · see citing works
Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment.
Higgins, V., & Adeli, K. (2017) · PubMed Central · Cited by 47 · see citing works
The impact of triglycerides on glucose tolerance: Lipotoxicity revisited
Seghieri, M., Tricò, D., & Natali, A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.04.010 · Cited by 42 · see citing works
Makino, A., Ishii, K., Murate, M., Hayakawa, T., Suzuki, Y., Suzuki, M., Ito, K., Fujisawa, T., Matsuo, H., Ishitsuka, R., et al. (2006) · Biochemistry · doi:10.1021/bi052104y · Cited by 43 · see citing works
Perona, J. S., & Ruíz-Gutiérrez, V. (2004) · Journal of Separation Science · doi:10.1002/jssc.200301723 · Cited by 42 · see citing works
n−3 long‐chain FA decrease serum levels of TG and remnant‐like particle‐cholesterol in humans
Hamazaki, K., Itomura, M., Huan, M., Nishizawa, H., Watanabe, S., Hamazaki, T., Sawazaki, S., TERASAWA, K., Nakajima, S., Terano, T., et al. (2003) · Lipids · doi:10.1007/s11745-003-1069-x · Cited by 41 · see citing works
Tan, K. C. B., Tso, A. W. K., Tam, S., Pang, R. W. C., & Lam, K. S. L. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00823.x · Cited by 41 · see citing works
Kim, J. Y., Park, J., Jeong, S., Schellingerhout, D., Park, J.-E., Lee, D. K., Choi, W. J., Chae, S. L., & Kim, D. (2011) · Journal of Clinical Neurology · doi:10.3988/jcn.2011.7.4.203 · Cited by 40 · see citing works
Izumida, T., Nakamura, Y., Hino, Y., & Ishikawa, S. (2019) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.49528 · Cited by 40 · see citing works
Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice
Alipour, A., Valdivielso, P., Elte, J. W. F., Janssen, H. W., Rioja, J., van der Meulen, N., van Mechelen, R., Njo, T. L., González‐Santos, P., Rietveld, A. P., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02635.x · Cited by 40 · see citing works
Triglycerides: risk factor or fellow traveler?
Forrester, J. S. (2001) · Current Opinion in Cardiology · doi:10.1097/00001573-200107000-00007 · Cited by 40 · see citing works
Liu, D., Wang, S.-L., Li, J., Liang, E., Yan, M.-Z., & Gao, W. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4698 · Cited by 39 · see citing works
Effects of diacylglycerol ingestion on postprandial hyperlipidemia in diabetes
Tada, N., Shoji, K., Takeshita, M., Watanabe, H., Yoshida, H., Hase, T., Matsuo, N., & Tokimitsu, I. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.10.006 · Cited by 39 · see citing works
Gavin, C., Sigal, R. J., Cousins, M., Menard, M. L., Atkinson, M., Khandwala, F., Kenny, G. P., Proctor, S. D., & Ooi, T. C. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.08.071 · Cited by 38 · see citing works
The role of diet and nutritional supplements in preventing and treating cardiovascular disease
Hill, A. M., Fleming, J. A., & Kris‐Etherton, P. M. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832f2fb1 · Cited by 38 · see citing works
Granér, M., Kahri, J., Nakano, T., Sarna, S. J., Nieminen, M. S., Syvänne, M., & Taskinen, M. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01720.x · Cited by 35 · see citing works
Baldassarre, D., Amato, M., Eligini, S., Barbieri, S. S., Mussoni, L., Frigerio, B., Kozàkovà, M., Tremoli, E., Sirtori, C. R., & Colli, S. (2006) · Annals of Medicine · doi:10.1080/07853890600852880 · Cited by 34 · see citing works
Ryan, J. J., Hanes, D. A., Schafer, M., Mikolai, J., & Zwickey, H. L. (2015) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2014.0063 · Cited by 34 · see citing works
Twickler, T. B., Dallinga‐Thie, G. M., Visseren, F. L. J., de Vries, W. R., Erkelens, D. W., & Koppeschaar, H. P. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020470 · Cited by 33 · see citing works
Holmer-Jensen, J., Hartvigsen, M. L., Mortensen, L. S., Astrup, A. V., de Vrese, M., Holst, J. J., Thomsen, C. E., & Hermansen, K. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.142 · Cited by 31 · see citing works
Nolting, P. R. W. D. S., Twickler, M., Dallinga‐Thie, G. M., Buirma, R. J. A., Hutten, B. A., & Kastelein, J. J. P. (2002) · Circulation · doi:10.1161/01.cir.0000025586.89221.4b · Cited by 31 · see citing works
Hiki, M., Shimada, K., Ohmura, H., Kiyanagi, T., Kume, A., Sumiyoshi, K., Fukao, K., Inoue, N., Mokuno, H., Miyazaki, T., et al. (2008) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.09.010 · Cited by 30 · see citing works
Yamazaki, M., Uchiyama, S., Xiong, Y., Nakano, T., Nakamura, T., & Iwata, M. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.08.029 · Cited by 30 · see citing works
Modifying the Sugar Moieties of Daunorubicin Overcomes P-gp-Mediated Multidrug Resistance
Battisti, R. F., Zhong, Y., Fang, L., Gibbs, S. T., Shen, J., Nadas, J., Zhang, G., & Sun, D. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060075v · Cited by 29 · see citing works
Lundahl, B., Hamsten, A., & Karpe, F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.102876 · Cited by 29 · see citing works
Self-citationHigh Plasma Level of Remnant-Like Particles Cholesterol in Familial Combined Hyperlipidemia
Graaf, J. D., van der Vleuten, G. M., ter Avest, E., Dallinga‐Thie, G. M., & Stalenhoef, A. F. H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1973 · Cited by 26 · see citing works
Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders
López-Pedrera, C., Barbarroja, N., Patiño-Trives, A. M., Luque-Tévar, M., Torres-Granados, C., Aguirre, M. A., Collantes‐Estévez, E., & Pérez‐Sánchez, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062012 · Cited by 28 · see citing works
Masuda, D., Kobayashi, T., Sairyou, M., Hanada, H., Ohama, T., Koseki, M., Nishida, M., Maeda, N., Kihara, S., Minami, T., et al. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.41343 · Cited by 27 · see citing works
Wu, B., Huang, J., Fukuo, K., Suzuki, K., Yoshino, G., & Kazumi, T. (2018) · International Journal of Endocrinology · doi:10.1155/2018/1289485 · Cited by 26 · see citing works
Beer, S., Moren, X., Ruiz, J. C., & James, R. W. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.09.005 · Cited by 26 · see citing works
Twickler, T. B., Dallinga‐Thie, G. M., ZELISSEN, P. M. J., Koppeschaar, H. P. F., & Erkelens, D. W. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01326.x · Cited by 26 · see citing works
Twickler, T. B., Cramer, M. J., Dallinga‐Thie, G. M., Chapman, M. J., Erkelens, D. W., & Koppeschaar, H. P. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030278 · Cited by 27 · see citing works
Ossewaarde, M. E., Dallinga‐Thie, G. M., Bots, M. L., van der Schouw, Y. T., Rabelink, T. J., Grobbee, D. E., & Westerveld, H. T. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01163.x · Cited by 26 · see citing works
Kasahara, A., Adachi, H., Hirai, Y., Enomoto, M., Fukami, A., YOSHIKAWA, K., Esaki, E., Yokoi, K., Ogata, K., Tsukagawa, E., et al. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt011 · Cited by 25 · see citing works
Effect of low concentration of diacylglycerol on mildly postprandial hypertriglyceridemia
Saito, S., Yamaguchi, T. F., Shoji, K., Hibi, M., Sugita, T., & Takase, H. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.062 · Cited by 25 · see citing works
Ai, M., Tanaka, A., Shoji, K., Ogita, K., Hase, T., Tokimitsu, I., & Shimokado, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.034 · Cited by 25 · see citing works
Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles
Schlitt, A., Hojjati, M. R., von Gizycki, H., Lackner, K. J., Blankenberg, S., Schwaab, B., Meyer, J., Rupprecht, H. J., & Jiang, X. (2004) · Journal of Lipid Research · doi:10.1194/jlr.c400011-jlr200 · Cited by 25 · see citing works
Epidemiology of Macrovascular Disease and Hypertension in Diabetes Mellitus
Tuomilehto, J. O., Rastenytė, D., Qiao, Q., & Jakovljević, D. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1002 · Cited by 25 · see citing works
Remnant Lipoproteins: Measurement and Clinical Significance
Jialal, I., & Devaraj, S. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.217 · Cited by 24 · see citing works
Johanson, E. H., Jansson, P., Gustafson, B., Lönn, L., Smith, U., Taskinen, M., & Axelsen, M. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01281.x · Cited by 22 · see citing works
Fonseca, M. I. H., de Almeida-Pititto, B., Benseñor, I. M., Toth, P. P., Jones, S. R., Blaha, M. J., Lotufo, P. A., Kulkarni, K. R., & Ferreira, S. R. G. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.09.005 · Cited by 21 · see citing works
Alssema, M., Schindhelm, R. K., Dekker, J. M., Diamant, M., Kostense, P. J., Teerlink, T., Scheffer, P. G., Nijpels, G., & Heine, R. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.021 · Cited by 20 · see citing works
Postprandial dyslipidemia in insulin resistant states in adolescent populations
Higgins, V., & Adeli, K. (2020) · Journal of Biomedical Research · doi:10.7555/jbr.34.20190094 · Cited by 20 · see citing works
Bruemmer, D., & Cho, L. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.121.012615 · Cited by 18 · see citing works
Yoshida, H., Kurosawa, H., Hirowatari, Y., Ogura, Y., Ikewaki, K., Abe, I., Saikawa, S., Domitsu, K., Ito, K., Yanai, H., et al. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-18 · Cited by 19 · see citing works
Insulin resistance and vessel endothelial function.
van Oostrom, A. J. H. H. M., Cabezas, M. C., & Rabelink, T. J. (2002) · Europe PMC (PubMed Central) · Cited by 18 · see citing works
Tzou, W. S., Douglas, P. S., Srinivasan, S. R., Chen, W., Berenson, G. S., & Stein, J. H. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-9-200505030-00009 · Cited by 18 · see citing works
Xu, X., Pandit, R. U., Han, L., Li, Y., & Guo, X. (2019) · Angiology · doi:10.1177/0003319719854296 · Cited by 17 · see citing works
Hepatic Syndecan-1 Changes Associate With Dyslipidemia After Renal Transplantation
Adepu, S., Katta, K., Tietge, U. J. F., Kwakernaak, A. J., Dam, W., van Goor, H., Dullaart, R. P. F., Navis, G. J., Bakker, S. J. L., & van den Born, J. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12842 · Cited by 17 · see citing works
Zhang, B., Böttcher, A., Imaizumi, S., Noda, K., Schmitz, G., & Saku, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.004 · Cited by 16 · see citing works
Zhang, B., Maeda, N., Okada, K., Tatsukawa, M., Sawayama, Y., Matsunaga, A., Kumagai, K., Miura, S., Nagao, T., Hayashi, J., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.005 · Cited by 16 · see citing works
Kakuda, H., Kobayashi, J., Nakato, M., & Takekoshi, N. (2013) · Cholesterol · doi:10.1155/2013/314170 · Cited by 15 · see citing works
Abdominal and gluteofemoral fat depots show opposing associations with postprandial lipemia
Christiansen, M. R., García‐Ureña, M., Borisevich, D., Grarup, N., Martínez, J. A., Oppert, J., Sørensen, T. I. A., Hansen, T. F., Blaak, E. E., & Kilpeläinen, T. O. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab219 · Cited by 15 · see citing works
van Hees, A. M. J., Saris, W. H. M., Dallinga‐Thie, G. M., Hul, G. B. J., Martínez, J. A., Oppert, J., Štich, V., Astrup, A. V., Arner, P., Sørensen, T. I. A., et al. (2008) · Journal of Nutrition · doi:10.3945/jn.108.094516 · Cited by 15 · see citing works
Chiu, C.-H., Burns, S., Yang, T.-J., Chang, Y. H., Chen, Y.-L., Chang, C.-K., & Wu, C.-L. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-177 · Cited by 12 · see citing works
- Authors
- Karpe, F., Boquist, S., Tang, R., Bond, G. M., de Faire, U., & Hamsten, A.
- Affiliations
- Karolinska Institutet (SE)
- Wake Forest University Health Sciences (US)
- Corresponding author
- Karpe, Fredrik
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 42
- Issue
- 1
- Pages
- 17-21
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W1936800019
- Cited by
- 174
- References
- 14
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 4 · 2012: 6
- FWCI
- 10.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- remnant-like particle cholesterol, remnant lipoproteins, triglyceride-rich lipoproteins, carotid intima-media thickness, atherosclerosis, LDL cholesterol, plasma triglycerides, postprandial lipemia, apolipoprotein B-48, apolipoprotein B-100, high-fat meal, middle-aged men
- MeSH terms
- Apolipoproteins, Arteriosclerosis, Carotid Arteries, Cholesterol, Fasting, Humans, Lipoproteins, Cholesterol, LDL, Male, Middle Aged, Triglycerides, Ultrasonography, Cohort Studies, Linear Models, Tunica Intima
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review